U. Who, Good governance for prison health in the 21st century. A policy brief on the organization of prison health. Copenhagen: Regional Office for Europe of the World Health Organization, 2013.

S. Fazel and J. Baillargeon, The health of prisoners, The Lancet, vol.377, issue.9769, pp.956-65, 2011.
DOI : 10.1016/S0140-6736(10)61053-7

H. Stover and . Michels, Drug use and opioid substitution treatment for prisoners, Harm Reduction Journal, vol.7, issue.1, p.17, 2010.
DOI : 10.1186/1477-7517-7-17

L. Michel, M. Jauffret-roustide, J. Blanche, O. Maguet, C. Calderon et al., Limited access to HIV prevention in French prisons (ANRS PRI2DE): implications for public health and drug policy, BMC Public Health, vol.9, issue.1, p.400, 2011.
DOI : 10.1186/1471-2334-9-113
URL : https://hal.archives-ouvertes.fr/inserm-00605495

K. Dolan, Prison research, Addiction, vol.104, issue.2, p.223, 2009.

L. Michel, M. Carrieri, and A. Wodak, Harm reduction and equity of access to care for French prisoners: a review, Harm Reduction Journal, vol.5, issue.1, p.17, 2008.
DOI : 10.1186/1477-7517-5-17

S. Wakai, D. Shelton, R. Trestman, and K. Kesten, Conducting research in corrections: challenges and solutions, Behavioral Sciences & the Law, vol.204, issue.2, pp.743-52, 2009.
DOI : 10.1002/bsl.894

A. Opitz-welke, K. Bennefeld-kersten, N. Konrad, and J. Welke, Prison suicides in Germany from, Int J Law Psychiatry, vol.36, pp.5-6386, 2000.

C. Macintyre, N. Kendig, L. Kummer, S. Birago, and N. Graham, Impact of Tuberculosis Control Measures and Crowding on the Incidence of Tuberculous Infection in Maryland Prisons, Clinical Infectious Diseases, vol.24, issue.6, pp.1060-1067, 1997.
DOI : 10.1086/513632

J. Walker, C. Illingworth, A. Canning, E. Garner, J. Woolley et al., Changes in mental state associated with prison environments: a systematic review, Acta Psychiatrica Scandinavica, vol.340, issue.6, pp.427-463, 2014.
DOI : 10.1111/acps.12221

W. Newman and C. Scott, Brown v. Plata: prison overcrowding in California, J Am Acad Psychiatry Law, vol.40, issue.4, pp.547-52, 2012.

J. Garcia-guerrero and A. Marco, [Overcrowding in prisons and its impact on health]. Revista espanola de sanidad penitenciaria 2012, pp.106-113

R. Jurgens, M. Nowak, and M. Day, HIV and incarceration: prisons and detention, Journal of the International AIDS Society, vol.14, issue.1, p.26, 2011.
DOI : 10.1310/GTQM-QRM1-FDW8-Y2FT

T. Kerr, K. Hayashi, L. Ti, K. Kaplan, P. Suwannawong et al., The impact of compulsory drug detention exposure on the avoidance of healthcare among injection drug users in Thailand, International Journal of Drug Policy, vol.25, issue.1, pp.171-175, 2014.
DOI : 10.1016/j.drugpo.2013.05.017

D. Wolfe and J. Cohen, Human Rights and HIV Prevention, Treatment, and Care for People Who Inject Drugs: Key Principles and Research Needs, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.55, issue.1, pp.56-62, 2010.
DOI : 10.1097/QAI.0b013e3181f9c0de

D. Wolfe, M. Carrieri, and D. Shepard, Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward, The Lancet, vol.376, issue.9738, pp.355-66, 2010.
DOI : 10.1016/S0140-6736(10)60832-X

B. Mathers, L. Degenhardt, H. Ali, L. Wiessing, M. Hickman et al., HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage, The Lancet, vol.375, issue.9719, pp.1014-1042, 2010.
DOI : 10.1016/S0140-6736(10)60232-2

L. Degenhardt, B. Mathers, P. Vickerman, T. Rhodes, C. Latkin et al., Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed, The Lancet, vol.376, issue.9737, pp.285-301, 2010.
DOI : 10.1016/S0140-6736(10)60742-8

K. Blankenship, A. Smoyer, S. Bray, and K. Mattocks, Black-White Disparities in HIV/AIDS: The Role of Drug Policy and the Corrections System, Journal of Health Care for the Poor and Underserved, vol.16, issue.4, pp.140-156, 2005.
DOI : 10.1353/hpu.2005.0077

L. Ti, K. Hayashi, K. Kaplan, P. Suwannawong, E. Wood et al., Contextual Factors Associated with Rushed Injecting Among People Who Inject Drugs in Thailand. Prevention science : the official journal of the Society for Prevention Research, 2014.

M. Hellard, C. Aitken, and J. Hocking, Tattooing in prisons???Not such a pretty picture, American Journal of Infection Control, vol.35, issue.7, pp.477-80, 2007.
DOI : 10.1016/j.ajic.2006.08.002

S. Larney, H. Kopinski, C. Beckwith, N. Zaller, D. Jarlais et al., Incidence and prevalence of hepatitis C in prisons and other closed settings: Results of a systematic review and meta-analysis, Hepatology, vol.192, issue.Suppl 1, pp.1215-1239, 2013.
DOI : 10.1002/hep.26387

M. Vescio, B. Longo, S. Babudieri, G. Starnini, S. Carbonara et al., Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis, Journal of Epidemiology & Community Health, vol.62, issue.4
DOI : 10.1136/jech.2006.051599

K. Carney, S. Dhalla, A. Aytaman, C. Tenner, and F. Francois, Association of tattooing and hepatitis C virus infection: A multicenter case-control study, Hepatology, vol.10, issue.Suppl. 1, pp.2117-2140, 2013.
DOI : 10.1002/hep.26245

S. Correctionnel and . Canada, Rapport d'évaluation. Initiative sur les pratiques de tatouage sécuritaires, Service correctionnel du Canada. Canada: Direction d'évaluation. Secteur de l'évaluation du rendement, 2009.

L. Macdonald, Licensing of Skin Piercing and Tattooing, Act 1982, Amendment Order 2006 St Andrew's House, Edinburgh: The Civic Government of Scotland, 2006.

S. Nolan, D. Lima, V. Fairbairn, N. Kerr, T. Montaner et al., The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users, Addiction, vol.32, issue.12, pp.2053-2062, 2014.
DOI : 10.1111/add.12682

J. Tsui, J. Evans, P. Lum, J. Hahn, and K. Page, Association of Opioid Agonist Therapy With Lower Incidence of Hepatitis C Virus Infection in Young Adult Injection Drug Users, JAMA Internal Medicine, vol.174, issue.12, pp.1974-81, 2014.
DOI : 10.1001/jamainternmed.2014.5416

A. Abdul-quader, J. Feelemyer, S. Modi, E. Stein, A. Briceno et al., Effectiveness of Structural-Level Needle/Syringe Programs to Reduce HCV and HIV Infection Among People Who Inject Drugs: A Systematic Review, AIDS and Behavior, vol.375, issue.9719, pp.2878-92, 2013.
DOI : 10.1007/s10461-013-0593-y

G. Birkhead, S. Klein, A. Candelas, O. Connell, D. Rothman et al., Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: A comprehensive approach, International Journal of Drug Policy, vol.18, issue.5, pp.417-442, 2007.
DOI : 10.1016/j.drugpo.2007.01.013

C. Van-den-berg, C. Smit, V. Brussel, G. Coutinho, R. Prins et al., Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users, Addiction, vol.361, issue.9, pp.1454-62, 2007.
DOI : 10.1111/j.1360-0443.2007.01912.x

K. Turner, S. Hutchinson, P. Vickerman, V. Hope, N. Craine et al., The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence, Addiction, vol.122, issue.11, pp.1978-88, 2011.
DOI : 10.1111/j.1360-0443.2011.03515.x